GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivoryon Therapeutics NV (FRA:05Y) » Definitions » E10

Vivoryon Therapeutics NV (FRA:05Y) E10 : €-1.50 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Vivoryon Therapeutics NV E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vivoryon Therapeutics NV's adjusted earnings per share data for the fiscal year that ended in Dec. 2023 was €-1.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.50 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Vivoryon Therapeutics NV was 5.50% per year. The lowest was 3.80% per year. And the median was 4.65% per year.

As of today (2024-06-06), Vivoryon Therapeutics NV's current stock price is € 2.705. Vivoryon Therapeutics NV's E10 for the fiscal year that ended in Dec. 2023 was €-1.50. Vivoryon Therapeutics NV's Shiller PE Ratio of today is .


Vivoryon Therapeutics NV E10 Historical Data

The historical data trend for Vivoryon Therapeutics NV's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivoryon Therapeutics NV E10 Chart

Vivoryon Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.63 -1.66 -1.52 -1.46 -1.50

Vivoryon Therapeutics NV Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.52 - -1.46 - -1.50

Competitive Comparison of Vivoryon Therapeutics NV's E10

For the Biotechnology subindustry, Vivoryon Therapeutics NV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivoryon Therapeutics NV's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivoryon Therapeutics NV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vivoryon Therapeutics NV's Shiller PE Ratio falls into.



Vivoryon Therapeutics NV E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vivoryon Therapeutics NV's adjusted earnings per share data for the fiscal year that ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.12/123.7729*123.7729
=-1.120

Current CPI (Dec. 2023) = 123.7729.

Vivoryon Therapeutics NV Annual Data

per_share_eps CPI Adj_EPS
201412 -2.304 99.543 -2.865
201512 -1.932 99.717 -2.398
201612 -1.784 101.217 -2.182
201712 -0.961 102.617 -1.159
201812 -0.940 104.217 -1.116
201912 -0.620 105.818 -0.725
202012 -0.830 105.518 -0.974
202112 -0.630 110.384 -0.706
202212 -1.280 119.345 -1.327
202312 -1.120 123.773 -1.120

Add all the adjusted EPS together and divide 10 will get our e10.


Vivoryon Therapeutics NV  (FRA:05Y) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vivoryon Therapeutics NV E10 Related Terms

Thank you for viewing the detailed overview of Vivoryon Therapeutics NV's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivoryon Therapeutics NV (FRA:05Y) Business Description

Traded in Other Exchanges
Address
Weinbergweg 22, Halle, SN, DEU, 06120
Vivoryon Therapeutics NV is a Germany-based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products include PQ912 and PQ1565. Geographically, the majority is from Greater China.

Vivoryon Therapeutics NV (FRA:05Y) Headlines

No Headlines